The legislation stemmed from a nationwide meningitis outbreak blamed on a tainted steroid produced by the now-closed New England Compounding Center in Framingham.
Federal officials said the outbreak, blamed on a tainted steroid, sickened about 750 people in 20 states, with 64 deaths.
The federal government has sent letters to states and other stakeholders across the country calling on them to encourage compounding pharmacies to register as a producer of sterile drugs in an effort to protect the public.
Attorneys for creditors of a Massachusetts pharmacy linked to a nationwide meningitis outbreak say they’ve reached a preliminary settlement that would set up a victim compensation fund worth more than $100 million.
Authorities in Michigan and Massachusetts said Monday that they will coordinate their separate state and federal criminal investigations of a company that sold steroid injection materials linked to a fungal meningitis outbreak that sickened hundreds of people in 20 states.
U.S. Attorney Carmen Ortiz will hold a news conference Monday to discuss a development in the investigation into the Framingham compounding pharmacy that made the steroid injections blamed for the fungal meningitis outbreak.
Last year’s deadly meningitis outbreak was traced to a now-closed pharmacy in Framingham.
The Massachusetts Senate has unanimously backed stricter regulations on drug compounding pharmacies like the one blamed for a deadly nationwide meningitis outbreak.
The stiffer regulations are aimed at drug compounding pharmacies like the one blamed for a deadly nationwide meningitis outbreak.
CDC records from a meningitis outbreak blamed on contaminated steroids from the New England Compounding Center in Massachusetts show no deaths in January, but federal court filings show Gokulbhai Patel of Goodlettsville, Tenn. died Jan. 13.
The report comes after a national meningitis outbreak traced to a Framingham pharmacy killed dozens of people.
The industry came under scrutiny after a meningitis outbreak traced to tainted steroids produced at the now-shuttered pharmacy in Framingham killed 58 people.
The decision comes months after a deadly nationwide meningitis outbreak was traced to a Massachusetts compounding pharmacy.
New England Compounding Center may have used patient lists from a Nashville clinic to mislead regulators. The fungal meningitis outbreak caused 55 deaths
A House committee is investigating whether the FDA could have prevented the deadly outbreak traced to a Framingham company.
The four owners received more than $16 million in wages and payouts during the firm’s final months.
The proposed regulations follow last year’s deadly meningitis outbreak linked to a Framingham pharmacy.
The New England Compounding Center sent a letter to UniFirst Corp. demanding that it take legal responsibility for claims against the pharmacy.
The company says in the filing it hopes to achieve a quicker and fairer payout to creditors than it could through piecemeal litigation.